Noradrenaline Kabi (Noradrenaline Tartrate)

Norepinephrine tartrate, the active ingredient in Noradrenaline Kabi, is a sympathomimetic presented as a sterile intravenous solution for intravenous use. It is employed to raise blood pressure and improve cardiac output in patients with severe hypotension, septic shock, cardiogenic shock, or cardiac arrest. GNH USA supplies Noradrenaline Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Noradrenaline Kabi is a sympathomimetic vasopressor used in critical‑care settings to support circulatory function. - Hypotension: restores adequate arterial pressure and organ perfusion. - Septic shock: counteracts vasodilatory failure and maintains systemic vascular resistance. - Cardiogenic shock: enhances cardiac output while supporting blood pressure. - Cardiac arrest: provides immediate vasoconstriction to improve coronary and cerebral perfusion during resuscitation.

Adverse reactions may occur with intravenous norepinephrine administration.

Common Side Effects: - Hypertension: excessive rise in blood pressure. - Tachycardia: increased heart rate. - Headache: pressure sensation. - Anxiety or restlessness. - Peripheral ischemia at infusion site.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Myocardial ischemia: reduced coronary blood flow. - Tissue necrosis: severe extravasation injury. - Severe bradycardia: paradoxical slowing of heart rate. - Pulmonary edema: fluid accumulation in lungs.

Use of Noradrenaline Kabi requires careful monitoring and specific safety measures. - Blood pressure monitoring: titrate infusion to maintain target MAP. - Cardiac rhythm observation: watch for arrhythmias or ischemia. - Dose titration: adjust gradually to avoid abrupt hypertension. - Extravasation prevention: ensure secure intravenous access and monitor site. - Caution in myocardial ischemia: use only when benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine may interact with other agents that affect vascular tone or cardiac function.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension. - Indirect sympathomimetics (e.g., ephedrine): additive pressor effect. - Beta‑blockers: may blunt desired cardiac response.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: potential for increased blood pressure. - Calcium channel blockers: may enhance hypotensive episodes if norepinephrine is weaned. - Diuretics: volume depletion can amplify pressor response.